DC
CAMP icon

Diametric Capital’s CAMP4 Therapeutics CAMP Stock Holding History

Diametric Capital’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.7K Buy
+14,446
New +$68.6K 0.02% 438

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Diametric Capital's CAMP Position: Q1 2026 in Review

Diametric Capital opened a new position in CAMP4 Therapeutics (CAMP) in Q1 2026: 14,446 shares worth $63.7K. The stake represents 0.02% of the portfolio and ranks #438 among its holdings.

46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Diametric Capital held 14,446 shares of CAMP4 Therapeutics worth $63.7K as of Q1 2026.
  • CAMP4 Therapeutics was a new Diametric Capital position in Q1 2026.
  • CAMP4 Therapeutics made up 0.02% of Diametric Capital's portfolio in Q1 2026, its #438 holding.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.